Application of Ectoin Containing Lozenges (EHT02) in Patients With Acute, Viral Pharyngitis.

Non-interventional Study to Investigate the Application of Ectoin Containing Lozenges (EHT02) in Patients With Acute, Viral Pharyngitis.

The goal of this non-interventional study is to investigate the safety, efficacy and tolerability of Ectoin Lozenges Honey Lemon (EHT02) compared to lozenges containing hyaluronic acid and islandic moss in the treatment of acute viral pharyngitis.

The current non-interventional study aims to investigate the efficacy and tolerability of Ectoin Lozenges Honey Lemon in patients suffering from acute viral pharyngitis. Participants receive treatments as part of routine medical care, and participants can choose one of two treatment options: a) Ectoin Lozenges Honey Lemon or b) lozenges containing hyaluronic acid and icelandic moss.

Efficacy will be studied by documentation of the following symptoms:

• pain on swallowing
• hoarseness
• urge to cough
• dry mouth and throat
• redness of oropharynx and larynx
• sore throat
• impairment of free breathing
• general feeling of illness

In parallel, participating patients will document their symptoms over the entire study duration in patient diaries.

The observation takes place over a period of seven days.

Inclusion Criteria:

• patients with acute viral pharyngitis

Exclusion Criteria:

• patients with known intolerance to one of the substances used
• Pregnancy
• Surgical Procedures in the mouth and throat region prior to the study
• Bacterial Pharyngitis
• symptoms in the throat since more than 5 days
• Contraindications according to the instructions for use